Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-30

Clinical Trial Update: Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of Brimonidine in patients with glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED